Summary:
Arizona Research Center is conducting a multicenter, Open-label, Single-arm Study to Evaluate the Long-term Use of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated with Painful Diabetic Neuropathy.
Qualified Participants Must:
• Be between 18 and 85 years of age
•
Have Type 1 or Type 2 diabetes mellitus with glycemic control that has been optimized on diet therapy, oral anti-hyperglycemic agents and/or insulin
•
More inclusion/exclusion criteria apply
Qualified Participants May Receive:
Compensation for time and travel